Bookbuilding IPO | ₹[.] Cr | Listing at NSE SME |
GNH India Pharmaceuticals Ltd. has withdrawn its Initial Public Offer (IPO) documents filed with the exchange on May 8, 2025.
GNH India Pharmaceuticals Ltd. IPO was a Book Build Issue
The equity shares were proposed to be listed on the NSE SME. Gretex Corporate Services Ltd. was the book running lead manager and Purva Sharegistry (India) Pvt.Ltd. was the registrar of the issue.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Sat, Sep 21, 2024 |
| Offer document withdrawn | Thu, May 8, 2025 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
Incorporated in , GNH India Pharmaceuticals Limited engaged in the business of sourcing, distributing, and delivering a comprehensive range of pharmaceutical products, including orphan drugs, biologics, biosimilars, vaccines, and comparator drugs for clinical trials.
With a portfolio of over 135,000 product lines sourced from more than 250 suppliers and 110 distributors across key pharmaceutical markets worldwide, the company caters to the entire spectrum of pharmaceutical trade, including wholesale, tender supplies, and name patient access.
The company exports to over 180 countries and has established a strong presence in markets like the USA, Canada, Europe, and the Middle East.
Services:
As September 21, 2024, the company has 27 employees.
Competitive Strengths:
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | 36.36 | 41.19 | 23.63 |
| Total Income | 40.86 | 33.30 | 23.15 |
| Profit After Tax | 4.87 | 5.17 | 3.83 |
| NET Worth | 28.99 | 13.42 | 9.24 |
| Reserves and Surplus | 18.83 | 12.42 | 8.24 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of Plant & Machinery for Setting up of Cold Storage Facility | 4.42 |
| 2 | Design, Development & Maintenance of Mobile Application | 3.98 |
| 3 | Advertisement and Digital Marketing Activities | 0.66 |
| 4 | Working Capital Requirements | 21.37 |
| 5 | General Corporate Purposes |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 22.99% |
| ROCE | 21.49% |
| RoNW | 16.81% |
| PAT Margin | 12.18% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 100% |
Purva Sharegistry (India) Pvt.Ltd.
Lead Manager Reports
GNH India Pharmaceuticals IPO is a SME IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The GNH India Pharmaceuticals IPO open and close dates are not available as of now.
Purva Sharegistry (India) Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in GNH India Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in GNH India Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in GNH India Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The GNH India Pharmaceuticals IPO dates are not announced. Please check back again after some time.
GNH India Pharmaceuticals IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in GNH India Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for GNH India Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the GNH India Pharmaceuticals IPO allotment status.
The GNH India Pharmaceuticals IPO listing date is not yet announced. The tentative date of listing is .
